Status:
NOT_YET_RECRUITING
HIPEC Surgery and Hemodynamics
Lead Sponsor:
Miray Gözde Özdemir
Conditions:
Hemodynamics
Cytoreductive Surgery
Eligibility:
All Genders
18+ years
Brief Summary
Hyperthermic Intraperitoneal Chemotherapy (HIPEC) involves the intraoperative administration of heated chemotherapeutic agents into the abdominal cavity following cytoreductive surgery (CRS). The incr...
Eligibility Criteria
Inclusion
- ≥18 years old Patients planned to undergo cytoreductive surgery with hyperthermic intraperitoneal chemotherapy
- ASA II-III-IV physical class
Exclusion
- \<18 years
- Emergency cases
Key Trial Info
Start Date :
April 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 15 2025
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT06922227
Start Date
April 1 2025
End Date
July 15 2025
Last Update
April 13 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ankara Etlik City Hospital
Ankara, Turkey (Türkiye)